asco lung cancer highlights, pt 9: the madeit study of predictive biomarkers for chemotherapy
Published 11 years ago • 78 plays • Length 9:49Download video MP4
Download video MP3
Similar videos
-
7:17
asco lung cancer highlights, part 8: the biomarkers france study
-
5:40
asco lung cancer highlights, pt 12: ganetespib with second line chemotherapy
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
6:38
asco lc highlights, pt 6: benefit of chemotherapy vs. egfr inhibitor therapy in second line
-
5:27
asco 2021 lung recap: lurbinectedin in small cell lung cancer and the failed atlantis trial
-
8:08
asco 2021 lung recap: mylung consortium: overall biomarker testing
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
5:39
gracecastuc 127 lung_molecular markers predicting the best chemotherapy to use in lung cancer
-
2:11
asco lung cancer highlights, pt 13: immune checkpoint inhibitor mpdl3280a in advanced nsclc
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
8:45
asco lung cancer highlights, part 2: optimizing radiation for stage iii nsclc
-
8:40
asco lung cancer highlights, part 3: immunotherapy for stage iii nsclc
-
6:10
asco 2021 lung recap: circulatory tumor dna
-
1:47
alk rearrangements: what are they, and who has them?
-
6:38
asco 2019 lung cancer round table: new cancer research: important results from afatinib trial
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
8:08
tumor treating fields for lung cancer - leading developments & current questions in lung cancer